We use cookies to understand how visitors search for and consume the information we provide, so that we can improve their experience. By browsing this website, you indicate your acceptance of the use of such cookiesAcceptRead more

Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Our products& pipeline
    • Diseases we target
    • GS010 for LHON
    • GS030 for Retinitis Pigmentosa
    • GS030 for Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
  • Investors& media
    • Company Overview
    • Press releases
    • Events & presentations
    • Stock information
    • Governance
    • Documentation

Events & presentations

21 Sep 2016 - 22 Sep 2016

Cell&Gene Therapy Europe, Berlin, Germany

04 May 2016 - 07 May 2016

ASGCT, Washington, DC, US

01 May 2016 - 05 May 2016

ARVO 2016, Seattle (Wash), US

22 Mar 2016

4th annual Cell&Gene Investor Day, New York City

27 Feb 2016 - 03 Mar 2016

NANOS 42nd Annual Meeting, Tucson (AZ), US

25 Jan 2016 - 27 Jan 2016

Phacilitate Cell&Gene Therapy, Washington DC

11 Jan 2016 - 15 Jan 2016

JP Morgan 34th Annual Healthcare Conference, San Francisco (CA), US

14 Nov 2015 - 17 Nov 2015

AAO, November 14-17, 2015, Las Vegas (CA), US

02 Nov 2015 - 04 Nov 2015

BioEurope, November 2-4, 2015, Munich, Germany

17 Sep 2015 - 20 Sep 2015

ESGCT, September 17-20, 2015, Helsinki, Finland

  • View previous 9 articles
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • View next 9 articles

Stay informed

Subscribe to the newsletter to get the latest GenSight Biologics news

Fields marked with an * are required
© 2019 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
Go back to the page of the page